Solidarity Fridays- Week 16

July 17, 2020

In today’s Solidarity Fridays episode, Joe and Kyle sit down and talk about various topics in the news and dive deep into somatic psychology. 

Subscribe Share

In today’s Solidarity Fridays episode, Joe and Kyle sit down and talk about various topics in the news and dive deep into somatic psychology. 

They first discuss Canadian mushroom life sciences company Cybin Corp’s recent collaboration with drug delivery company IntelGenx to create an orally dissolvable film to administer psilocybin in controlled doses. This feels to them like the early days in the expansion of cannabis offerings, and how, for people with difficulty swallowing or pill-phobia, this may be the best option for psilocybin. 

Next, they talk about a recent study of 65 U.S. Special Operations Forces veterans who took Ibogaine on day 1 and 5-MeO-DMT on day 3 (with surrounding processing and integration time) and the amazing results, including most participants rating their psychedelic experiences as one of the top five most personally meaningful and spiritually significant experiences of their lives. Joe brings up a seldom-asked question on whether non-combat veterans should be differentiated from combat veterans in these studies and therapies. 

The last article they look at highlights a study where physicians used a new selective‐dose cannabis inhaler to administer microdoses of THC (either .5mg or 1mg) to patients with great results in decreasing pain without affecting cognitive performance. They talk about their experiences with low dose edibles and how they’ve seen great benefits from tiny amounts. 

They then discuss many aspects of Kyle’s area of expertise (and often not mentioned in-depth on this podcast), Somatic psychology. They talk about how breathwork and a session with a physical therapist led Kyle to this practice, the concept of character armoring, William Reich’s idea of neurosis being represented throughout the entire organism, how the western mind focuses on the material body, trying to fix things, and technique, how the smallest muscle quivering during a breathwork session can show where work needs to be done, and the difficulty people have in discussing the body- how it’s almost a secret language only learned through experience or their therapist’s suggestive questions on whether they’re feeling a certain emotion or even seeing a color.

Notable quotes

“Thinking about my early years exploring psychedelics, I was so focused on the mind- the experience was outside of me, the knowledge and the wisdom was in the numinous. And that’s where I was going to find all the answers. …It wasn’t until I had my first breathwork experience, where it was such a somatic experience- where I was feeling the experience in my body vs. externalizing my experience outside of my body and viewing it more as this thing of novelty- of something I’ve never experienced before. Actually having that experience and feeling it within myself, [I realized] I have felt this before, and it’s inside of me.” -Kyle

“[Bodywork] just reveals how much is not immediately available in the day-to-day consciousness. There’s so much happening- so much stored in our body that we just don’t even really have a handle on it. …My favorite line (which, I’m starting to feel like I’m cheating) is: “Mind is, at the very least, diffused throughout the body.” -Joe

“As a culture, we’re so body-oriented at times, right? We think about diet, exercise, yoga has turned more into more of an exercise than a lifestyle or practice. …We’re so focused more on the physical, material body than the emotional body, and that’s something that’s really hard to tap into.” -Kyle

“Try not to set out with some of these goals that ‘we need to change this.’ What does it feel like to just maybe feel some of these things?” -Kyle


Psychedelics For Seniors: A New Sublingual Option

Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans

The pharmacokinetics, efficacy, and safety of a novel selective‐dose cannabis inhaler in patients with chronic pain: A randomized, double‐blinded, placebo‐controlled trial


Support the show

Navigating Psychedelics